Cargando…
Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
PURPOSE: This study examined adherence to screening for fecal immunochemical test (FIT). METHODS: Adults (≥ 50–75) with a FIT between 1/1/2014 and 6/30/2019 in MarketScan administrative claims were selected (index = earliest FIT). Patients were followed for 10 years pre- and 3 years post-index. Pati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885483/ https://www.ncbi.nlm.nih.gov/pubmed/34729622 http://dx.doi.org/10.1007/s00384-021-04055-w |
_version_ | 1784660430959935488 |
---|---|
author | Fisher, Deborah A. Princic, Nicole Miller-Wilson, Lesley-Ann Wilson, Kathleen DeYoung, Kathryn Ozbay, A. Burak Limburg, Paul |
author_facet | Fisher, Deborah A. Princic, Nicole Miller-Wilson, Lesley-Ann Wilson, Kathleen DeYoung, Kathryn Ozbay, A. Burak Limburg, Paul |
author_sort | Fisher, Deborah A. |
collection | PubMed |
description | PURPOSE: This study examined adherence to screening for fecal immunochemical test (FIT). METHODS: Adults (≥ 50–75) with a FIT between 1/1/2014 and 6/30/2019 in MarketScan administrative claims were selected (index = earliest FIT). Patients were followed for 10 years pre- and 3 years post-index. Patients at increased risk for CRC or with prior screening were excluded. Year over year adherence was measured post-index. RESULTS: Of 10,253 patients, the proportion adherent to repeat testing at year 2 was 23.4% and 10.6% at year 3. Of 76.6% not adherent in year 2, 5.4% were adherent in year 3. CONCLUSION: Results suggest adherence to FIT tests is poor, minimizing potential benefits. Future studies are needed to consider alternative test options and whether more choice will improve long-term adherence. |
format | Online Article Text |
id | pubmed-8885483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-88854832022-03-02 Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer Fisher, Deborah A. Princic, Nicole Miller-Wilson, Lesley-Ann Wilson, Kathleen DeYoung, Kathryn Ozbay, A. Burak Limburg, Paul Int J Colorectal Dis Short Communication PURPOSE: This study examined adherence to screening for fecal immunochemical test (FIT). METHODS: Adults (≥ 50–75) with a FIT between 1/1/2014 and 6/30/2019 in MarketScan administrative claims were selected (index = earliest FIT). Patients were followed for 10 years pre- and 3 years post-index. Patients at increased risk for CRC or with prior screening were excluded. Year over year adherence was measured post-index. RESULTS: Of 10,253 patients, the proportion adherent to repeat testing at year 2 was 23.4% and 10.6% at year 3. Of 76.6% not adherent in year 2, 5.4% were adherent in year 3. CONCLUSION: Results suggest adherence to FIT tests is poor, minimizing potential benefits. Future studies are needed to consider alternative test options and whether more choice will improve long-term adherence. Springer Berlin Heidelberg 2021-11-02 2022 /pmc/articles/PMC8885483/ /pubmed/34729622 http://dx.doi.org/10.1007/s00384-021-04055-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Short Communication Fisher, Deborah A. Princic, Nicole Miller-Wilson, Lesley-Ann Wilson, Kathleen DeYoung, Kathryn Ozbay, A. Burak Limburg, Paul Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer |
title | Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer |
title_full | Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer |
title_fullStr | Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer |
title_full_unstemmed | Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer |
title_short | Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer |
title_sort | adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885483/ https://www.ncbi.nlm.nih.gov/pubmed/34729622 http://dx.doi.org/10.1007/s00384-021-04055-w |
work_keys_str_mv | AT fisherdeboraha adherencetofecalimmunochemicaltestscreeningamongadultsataverageriskforcolorectalcancer AT princicnicole adherencetofecalimmunochemicaltestscreeningamongadultsataverageriskforcolorectalcancer AT millerwilsonlesleyann adherencetofecalimmunochemicaltestscreeningamongadultsataverageriskforcolorectalcancer AT wilsonkathleen adherencetofecalimmunochemicaltestscreeningamongadultsataverageriskforcolorectalcancer AT deyoungkathryn adherencetofecalimmunochemicaltestscreeningamongadultsataverageriskforcolorectalcancer AT ozbayaburak adherencetofecalimmunochemicaltestscreeningamongadultsataverageriskforcolorectalcancer AT limburgpaul adherencetofecalimmunochemicaltestscreeningamongadultsataverageriskforcolorectalcancer |